Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gerardo Perez Roman

Orthopaedic Surgery San Juan, PR Medical Doctor

NPI 1144233602 CMS profile 1050534

576 Cesar Gonzalez Ave, Suite 402, San Juan, PR 00918

Open in the dashboard

General payments

$11,430

62 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gerardo Perez Roman of San Juan, PR is reported in the CMS Open Payments database as having received $11,430 across 62 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $266 2
2024 General $4,139 19
2023 General $263 3
2022 General $3,214 14
2021 General $112 1
2019 General $3,436 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gerardo Perez Roman
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Gerardo Perez Roman were reported at $266. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Gerardo Perez Roman Orthopaedic Surgery median Middle half National median
2019 $3,436 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $112 $520 $117–$2,495 $132
2022 $3,214 $598 $128–$2,731 $149
2023 $263 $461 $128–$2,264 $160
2024 $4,139 $497 $134–$2,475 $164
2025 $266 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $4,283 36 payments
  2. Smith+Nephew, Inc. $3,465 16 payments
  3. RMC Orthopedic & Surgical, Inc. $3,194 4 payments
  4. Johnson and Johnson International $257 4 payments
  5. Stryker Corporation $230 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,717 11 payments
  2. Education $4,552 3 payments
  3. Food and Beverage $2,161 48 payments
Products named General payments · program years 2019–2025
  1. Bioinductive Implant with Arthroscopic Delivery System - Medium $2,870 11 payments
  2. Bone Anchors with Arthroscopic Delivery System $395 3 payments
  3. HEALICOIL Sports Med Shoulder $359 3 payments
  4. MICRORAPTOR $276 2 payments
  5. CLEAR-TRAC $226 2 payments
  6. Mini-Open Latarjet $148 2 payments
  7. HEALICOIL Sports Med Shoulder $148 2 payments
  8. GLOBAL $124 1 payment
  9. HEALIX $124 1 payment
  10. DELTA $124 1 payment
  11. Other $996 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

181

Median for Orthopedic Surgery: 203

Drug cost

$3,003

Median for Orthopedic Surgery: $1,433

Branded share of claims

21.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Etodolac Generic 91 $1,744
Cefadroxil Generic 40 $365
Acetaminophen-Codeine Acetaminophen With Codeine Brand 19 $360
Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen Brand 20 $268
Ketorolac Tromethamine Generic 11 $265

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$22,174

Medicare's payments for the services billed

Medicare patients

128

Average age 76

Services billed

357

77 women, 51 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 59%
Chronic kidney disease 26%
Cancer 21%
Osteoporosis 20%
Ischemic heart disease 18%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

62 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record